Navigation Links
VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps
Date:12/2/2013

y studies show compliance rates of between 30-60%[i] for faecal blood tests, likely due to the uncomfortable nature of the test.  Meanwhile, a US study found that less than 40%[ii] of people who were offered a colonoscopy screening actually attended.

Encouragingly, uptake of diagnostic blood tests is much higher, with one study showing annual prostate cancer screening compliance at higher than 80%[iii]. When VolitionRx's NuQ blood test is made publically available, higher uptake could be very likely. Additionally, if the research team continue to identify at least 50% of polyps this could also have vast implications for diagnosing earlier-stage colorectal cancers.

Professor Hans Jorgen Nielsen, Professor of Surgical Oncology at Hvidovre Hospital in Denmark, recently expanded his prospective study evaluating VolitionRx's NuQ panel as a colorectal cancer screening tool. He comments, "The 85% detection rate seen in this latest research is on par with rates achieved by faecal occult blood tests. If we could improve screening compliance by offering the public a simple, less intrusive test that is just as accurate, we could detect even more colorectal cancer cases in the earlier stages and survival rates could drastically improve."

This test has the potential to become a global first choice diagnostic tool, replacing faecal occult blood tests and preventing unnecessary colonoscopies around the world. The company hopes to apply for CE mark early next year and FDA approval roughly a year later.

Colorectal cancer is the third most prevalent cancer and fourth most common cause of cancer death worldwide.

About VolitionRx

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nu
'/>"/>

SOURCE VolitionRx Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark
2. VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant
3. VolitionRx Embarks on Colorectal Cancer Trial with Hvidovre Hospital, Denmark
4. VolitionRxs Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers
5. International Survey Finds Self-Administered Treatment on the Rise Among Hereditary Angioedema Patients
6. Report Finds Healthcare Sales Job Openings are Down but Increasing
7. BioInformatics LLC—New Report Finds High Degree of Satisfaction With Instrumentation Performance Among Researchers
8. Study finds plasmin -- delivered through a bubble -- more effective than tPA in busting clots
9. Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged Adult Stem Cells Can Be Functionally Reprogrammed To Act Like Younger Cells
10. PwCs Health Research Institute Finds Shortage of Health IT Workers Could Slow Industry Progress
11. EU Study Finds UK Health Product Benefit Metric Flawed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cbgl72/middle_east_and ) has ... Africa Biomedical Sensors Market - Growth, Trends & Forecasts ... The Middle East & Africa ... 2018 at a CAGR of 3.26% over the period ... sensors that are adaptable to the genetic formulation of ...
(Date:8/31/2015)... Aug. 31, 2015  US-Australian drug discovery company, ... today confirmed its comprehensive scientific review has identified ... in areas of unmet patient need. Novogen is ... preclinical projects prior to entering into Phase 1 ... Acting Chief Executive Officer, Iain Ross ...
(Date:8/31/2015)... Trimb Healthcare AB ("Trimb") today announced that ... BV ("YouMedical"), a Dutch OTC company with operations in ... approximately EUR 16 million, with solid growth and leading ... is to build a leading international OTC company, and ... YouMedical gives us a stronger North European OTC platform, ...
(Date:8/31/2015)... ... 31, 2015 , ... Proove Biosciences, Inc. is a finalist for the Outstanding ... Awards. , Now in its 22nd year, this premier awards event celebrates the best ... nation and around the world. The OC Tech Alliance will announce all winners at ...
Breaking Biology Technology:Middle East & Africa Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts to 2020 2Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 2Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 3Proove Biosciences, Inc. Named a Finalist for 22nd OC Tech Alliance High-Tech Awards for Company of the Year 4
... SAN JOSE, Calif., April 4, 2011 Researchers ... Institute of Bioengineering and Nanotechnology have made a ... were shown to physically detect and destroy antibiotic-resistant ... known as MRSA, while leaving healthy cells unharmed. ...
... TORONTO, April 4, 2011 Generex Biotechnology ... today the publication of a report comparing ... peptide vaccines designed for immunotherapy of breast ... developed by the Company,s wholly-owned subsidiary, Antigen ...
... CryoLife, Inc. (NYSE: CRY ), an implantable biological ... it has filed an IDE with the United ... for the purpose of obtaining Pre-Market Approval (PMA) to distribute ... or following traumatic injuries. PerClot is a ...
Cached Biology Technology:IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment 2IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment 3IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment 4Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 2Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 3Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research 4CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 2CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 3CryoLife Files Investigational Device Exemption (IDE) to Begin Clinical Trials for PerClot® in the U.S. 4
(Date:8/20/2015)... 20, 2015   Sensory, Inc ., a ... user experience and security of consumer electronics through ... that its TrulySecure™ is the first ... be FIDO Certified™. The FIDO (Fast ... the FIDO UAF (Universal Authentication Framework) 1.0 specifications, ...
(Date:8/18/2015)... Aug. 18, 2015  Navitas today announced ... to the Submission Content Management webinar scheduled ... non-profit forum. Dedicated to the Implementation of Regulatory ... platform for industry, vendors, health authorities, consultants ... work towards a standard method of implementing ...
(Date:8/12/2015)... 12, 2015   MedNet Solutions , an innovative ... of clinical research, is proud to announce that ... SaaS-based eClinical technology platform, has led the way to ... quarters of 2015.   Q2 2015 and Q1 2015 ... by contract value sold in the company,s 15 year ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2
... available to health officials and businesses, a Purdue University ... of melamine in infant formula. Using infrared lasers ... of food science, was able to detect melamine in ... five minutes or less. Melamine, a synthetic chemical used ...
... Mittermeier, the president of Conservation International and a global ... Peterson Medal from the Harvard Museum of Natural History. ... strategist who has written more than 500 scientific and ... He has described 11 species new to science, had ...
... cancer researchers at The Ohio State University has ... certain proteins that may make good biomarkers in ... liquid chromatography-mass spectrometry (LC-MS) can measure variations in ... and store DNA. The technology accurately detected differences ...
Cached Biology News:Researcher: Lasers used to detect melamine in baby formula 2Study validates means to measure possible leukemia marker 2
... The Sub-Plates are E.Coli glycerol stocks ... well contains 50 cDNA clones with approximately ... of the a master plate well, the ... 96-well PCR to identify the positive well(s). ...
... system designed for flexibility and routine operation. ... ion lens, true hyperbolic quadrupole and high-speed ... widest range of sample types and applications. ... as standard Agilents unique ShieldTorch System, which ...
... a fully automated microplate luminescence reader ... possible range of applications based on ... luciferase, -galactosidase, gene activities with luminescence ... Luminescent Immunoassays Cell-based assays (cytotoxity ...
... are specifically depleted of a single complement ... protein, the alternative and classical pathways are ... for the detection and quantitation of hemolytically ... used to assess complement activation in non-human ...
Biology Products: